Endocrinology Test
|
|
| 1. 21 hydroxylase deficiency: |
|
|
| 2. Which of the following is the principal inhibitor of prolactin: |
|
|
| 3. In Europe, first-line treatment option in Graves’ disease is: |
|
|
| 4. The acute treatment of tetany is made with: |
|
|
| 5. The treatment of thyrotoxic phase of subacute thyroiditis includes: |
|
|
| 6. The following are true regarding nephrogenic diabetes insipidus: |
|
|
| 7. In thyroid nodules total thyroidectomy is performed in: |
|
|
| 8. The following are true regarding primary adrenal insufficiency: |
|
|
| 9. Bone formation agents used as osteoporosis treatment are represented by: |
|
|
| 10. The pathophysiological mechanisms involved in secondary hyperparathyroidism from chronic renal failure are represented by: |
|
|
| 11. The classic diagnostic TRIADE of Graves disease is represented by: |
|
|
| 12. Type II of primary osteoporosis: |
|
|
| 13. Subclinical hyperparathyroidism has to be considered in the following situations: |
|
|
| 14. Addison's disease: |
|
|
| 15. Which of the following statements regarding corticotropin-releasing hormone are true: |
|
|
| 16. Patients with Cushing syndrome can present: |
|
|
| 17. The treatment of GH deficiency in children: |
|
|
| 18. The differential diagnostic of prolactinoma has to be made with: |
|
|
| 19. Which of the following statements regarding the treatment of chronic adrenal insufficiency are true: |
|
|
| 20. In adult hypothyroidism the clinical picture includes: |
|
|
| 21. The following are true regarding medical treatment of GH deficiency: |
|
|
| 22. The mortality rate in differentiated thyroid cancer at 5 years are: |
|
|
| 23. The control mechanisms of arginine vasopressin release include: |
|
|
| 24. The etiology of pituitary insufficiency includes: |
|
|
| 25. Combined regulation mechanisms in the endocrine system are: |
|